R97.21 is the authoritative medical code for Rising PSA following treatment for malignant neoplasm of prostate. This classification is used in medical billing and clinical recording to specify the clinical criteria for rising psa following treatment for malignant neoplasm of prostate (ICD-10-CM R97.21), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: YES. This is a valid, specific, and billable ICD-10-CM reference.
Official ICD-10-CM classifications in the same code family as R97.21, with their registry titles.
Clinical term phrases from the official ICD-10-CM Index to Diseases and Injuries that map to this code.
Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures: